Release Date: 21/09/20 09:18 Summary: Rhinomed Limited Audited Financial Report FY20 Price Sensitive: No Download Document 1.29MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%